FIELD: medicine. SUBSTANCE: invention describes dermatan sulfate or its salt with intrinsic viscosity value 0.8 (100 ml/g) or above using 0.2 M sodium chloride solution as solvent at 30 ± 0.1 C. Indicated dermatan sulfate has 0.15% or less of heparin or heparan sulfate determined by method involving treatment with enzymes that cleave heparin or heparan sulfate and high pressure liquid chromatography. Dermatan sulfate has also 0.07% or less of heparin or heparan sulfate determined by inhibitory effect of active factor in the presence of antithrombin-III using heparin isolated from cow guts as standard substance or 0.05% of less of heparin or heparan sulfate determined by inhibitory effect of active factor-II in the presence of antithrombin-III using heparin isolated from cow guts as standard substance. Dermatan sulfates or their salts are antithrombotic agents that inhibit thrombus distribution and stimulate their lysis. Invention describes also antithrombosis agents, method of prophylaxis or treatment of patients with disseminated intravascular coagulation syndrome and method of treatment of patients with myocardium infarction. EFFECT: improved method of prophylaxis and treatment, valuable medicinal properties. 18 cl, 8 tbl, 6 dwg, 9 ex
Title |
Year |
Author |
Number |
PHOTOCONSOLIDATED DERIVATIVE OF GLYCOSEAMINOGLYCAN, CROSS- -LINKED DERIVATIVE OF GLYCOSEAMINOGLYCAN AND METHODS OF THEIR SYNTHESIS, COMPOSITION FOR MEDICINAL USE, METHOD OF PREVENTION OF CELLULAR AND TISSUE ADHESION |
1993 |
- Takekhisa Matsuda
- Minoo Dzh.Mogkhaddam
- Katsukijo Sakurai
|
RU2139886C1 |
AGENT ENHANCING ANTI-INFLAMMATORY EFFECT OF IMMUNODEPRESSANT (VERSIONS), METHOD OF ENHANCEMENT OF ANTI-INFLAMMATORY EFFECT OF IMMUNODEPRESSANT, METHOD OF INFLAMMATION TREATMENT |
1996 |
- Kiogasima Mamoru
- Asari Akira
|
RU2176509C2 |
THROMBOLYTIC AGENTS |
1995 |
- Khirojuki Utijama
- Masakhiro Ivaki
|
RU2142799C1 |
CHONDROITINASE, METHOD OF ITS PREPARING AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF |
1993 |
- Nobukazu Khasimoto
- Khideo Motizuki
- Akio Khamai
- Siniti Isikava
- Misako Torikai
- Isao Mijati
|
RU2144833C1 |
SUCCINIC ACID DERIVATIVES, SUCCINIC ACID-POLYSACCHARIDE DERIVATIVE, METHOD OF PREPARING SUCCINIC ACID-GLYCOSAMINOGLYCANE DERIVATIVE, METHOD OF PREPARING SUCCINIC ACID-POLYAMINOSACCHARIDE DERIVATIVE, AND METHOD OF PREPARING CROSS- LINKED SUCCINIC ACID-POLYSACCHARIDE DERIVATIVE |
1995 |
- Mitinori Vaki
- Kendzi Mijamoto
- Josikhiro Motani
|
RU2169136C2 |
POLYPEPTIDES OR THEIR SALTS AND PHARMACEUTICAL COMPOSITION |
1992 |
- Nobutaka Fudzii[Jp]
- Naoki Jamamoto[Jp]
- Akiesi Matsumoto[Jp]
- Mitinori Vaki[Jp]
|
RU2083589C1 |
METHOD OF INHIBITING THROMBUS FORMATION AND ACCELERATION OF FIBRINOLYSIS WITH DNA APTAMERS INHIBITING ACTIVITY OF THROMBIN IN EXPERIMENT |
2014 |
- Dobrovol'Skij Anatolij Borisovich
- Mazurov Aleksej Vladimirovich
- Spiridonova Vera Alekseevna
|
RU2559545C1 |
FRACTION OF KERATANSULFATE OLIGOSACCHARIDES AND PHARMACEUTICAL PREPARATION CONTAINING THEREOF |
1995 |
- Marujama Khirosi
- Morikava Kijosi
- Tavada Akira
- Mijauti Satosi
- Josida Kejiti
- Asari Akira
|
RU2173154C2 |
ANTICOAGULANT DRUG, WHICH IS A SYNTHETIC DIPEPTIDE Ac-Trp-Arg-Pip·HCl, A PHARMACEUTICAL COMPOSITION COMPRISING SAID ANTICOAGULANT DRUG |
2019 |
- Voyushina Tatyana Lvovna
- Dubovskaya Svetlana Igorevna
- Puchnina Svetlana Vladimirovna
- Sokolenko Nikolaj Ivanovich
- Yarotskij Sergej Viktorovich
|
RU2712194C1 |
POLYPEPTIDES OR THEIR SALTS, PHARMACEUTICAL COMPOSITION SHOWING ANTIVIRAL ACTIVITY WITH RESPECT TO HUMAN IMMUNODEFICIENCY VIRUS |
1991 |
- Nobutaka Fudzii[Jp]
- Naoki Jamamoto[Jp]
|
RU2073685C1 |